Joint statement: Supply allocations of intravenous tocilizumab (Actemra) during serious shortage
Published
Related content
-
Limited Ozempic supplies to commence distribution in Australia
Supplies of Ozempic (semaglutide) have begun distribution in Australia but will remain quite limited for some time. -
TGA Provisional Approval of Roche Products Pty Ltd COVID-19 treatment, tocilizumab (ACTEMRA)
On 1 December 2021, the TGA granted provisional approval to Roche Products Pty Ltd for the use of tocilizumab (ACTEMRA) for the treatment of COVID-19. -
COVID-19 treatment: Roche Products Pty Ltd, tocilizumab (ACTEMRA)
On 1 December 2021, the TGA granted provisional approval to Roche Products Pty Ltd for the use of tocilizumab (ACTEMRA) for the treatment of COVID-19.